Menu Search
Equities

Devonian Health Group Inc

DVHGF:QBB

Devonian Health Group Inc

Actions
  • Price (USD)0.10
  • Today's Change0.00 / 0.00%
  • Shares traded5.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 17 2024 18:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Devonian Health Group Inc's net income fell 33.39% from a loss of 3.45m to a larger loss of 4.60m despite flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 121.69% to 179.34%.
Gross margin30.95%
Net profit margin-32.50%
Operating margin-32.50%
Return on assets-14.37%
Return on equity-23.31%
Return on investment-23.15%
More ▼

Cash flow in CADView more

In 2023, Devonian Health Group Inc increased its cash reserves by 80.48%, or 2.26m. Cash Flow from Investing totalled 5.00m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 4.36m for operations while cash generated from financing totalled 1.61m.
Cash flow per share-0.0187
Price/Cash flow per share--
Book value per share0.09
Tangible book value per share0.0222
More ▼

Balance sheet in CADView more

Devonian Health Group Inc appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 5.06m.
Current ratio1.07
Quick ratio1.06
Total debt/total equity0.1636
Total debt/total capital0.1406
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.